**Core Concept**
Acute ulcerative colitis (AUC) is a type of inflammatory bowel disease (IBD) characterized by chronic inflammation and ulceration of the colonic mucosa. The primary goal of treatment is to induce and maintain remission, prevent complications, and improve quality of life. Treatment strategies for AUC involve a combination of medications, lifestyle modifications, and in some cases, surgical intervention.

**Why the Correct Answer is Right**
The best treatment for inducing remission in acute ulcerative colitis is a class of medications known as aminosalicylates, specifically sulfasalazine (Azulfidine). Sulfasalazine works by releasing 5-aminosalicylic acid (5-ASA) in the colon, where it acts as an anti-inflammatory agent by inhibiting the production of pro-inflammatory mediators and reducing the adhesion of leukocytes to the colonic mucosa. This leads to a decrease in inflammation and ulceration, promoting healing of the colonic mucosa.

**Why Each Wrong Option is Incorrect**

* **Option A:** Corticosteroids, such as prednisone, are used to treat acute exacerbations of AUC but are not the best choice for inducing remission due to their side effects and the risk of corticosteroid dependence.
* **Option B:** Immunomodulators, such as azathioprine, are used to maintain remission in AUC but are not the first-line treatment for inducing remission.
* **Option C:** Janssen's biologic therapy, Vedolizumab, is used to treat moderate to severe ulcerative colitis but is not the best choice for inducing remission in acute ulcerative colitis.

**Clinical Pearl / High-Yield Fact**
Sulfasalazine is a prodrug that requires bacterial metabolism in the colon to release 5-ASA, which is the active anti-inflammatory agent. This unique mechanism of action highlights the importance of the gut microbiome in the treatment of inflammatory bowel disease.

**Correct Answer:** C. Sulfasalazine (Azulfidine)